Zhitong Financial App News, Yasheng Pharmaceutical (06855.HK) announced that on July 20, 2026 (US Eastern Time), the company (qualifying as a “well-known mature issuer”) has submitted an F-3 automatic storage shelf registration statement (registration number 333-297559) to the US Securities and Exchange Commission (SEC) for filing. The registration statement contains two prospectuses: (i) a basic prospectus covering the offering, issuance and sale of American Depositary Shares by the Company through one or more offers from time to time, with each American Depositary Share representing the Company's four ordinary shares with a face value of $0.0001 per share; and (ii) a sales agreement prospectus (ATM prospectus), which covers the sale of up to US$200 million of the Company's American Depositary Shares at market value as described below (recommended ATM scheme).

Zhitongcaijing · 2d ago
Zhitong Financial App News, Yasheng Pharmaceutical (06855.HK) announced that on July 20, 2026 (US Eastern Time), the company (qualifying as a “well-known mature issuer”) has submitted an F-3 automatic storage shelf registration statement (registration number 333-297559) to the US Securities and Exchange Commission (SEC) for filing. The registration statement contains two prospectuses: (i) a basic prospectus covering the offering, issuance and sale of American Depositary Shares by the Company through one or more offers from time to time, with each American Depositary Share representing the Company's four ordinary shares with a face value of $0.0001 per share; and (ii) a sales agreement prospectus (ATM prospectus), which covers the sale of up to US$200 million of the Company's American Depositary Shares at market value as described below (recommended ATM scheme).